Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,093 | -41,565 | -20,311 | -65,373 | -49,278 |
| Depreciation Amortization | 1,931 | 1,269 | 628 | 2,431 | 1,817 |
| Accounts receivable | N/A | N/A | N/A | 1,034 | 465 |
| Accounts payable and accrued liabilities | -610 | -168 | 41 | 519 | 601 |
| Other Working Capital | -4,506 | -4,897 | -1,487 | -325 | -14 |
| Other Operating Activity | 4,253 | 2,537 | 1,288 | 6,682 | 6,027 |
| Operating Cash Flow | $-62,025 | $-42,824 | $-19,841 | $-55,032 | $-40,382 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 49,537 | 32,659 | 10,482 | -119,821 | -118,919 |
| PPE Investments | -2,166 | -1,566 | -511 | -642 | -578 |
| Investing Cash Flow | $47,371 | $31,093 | $9,971 | $-120,463 | $-119,497 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -98 | -66 | -33 | -149 | -116 |
| Common Stock Issued | 371 | 272 | 272 | 166,558 | 166,535 |
| Other Financing Activity | -143 | -39 | 0 | -4,183 | -4,163 |
| Financing Cash Flow | $130 | $167 | $239 | $162,226 | $162,256 |
| Beginning Cash Position | 40,493 | 40,493 | 40,493 | 53,762 | 53,762 |
| End Cash Position | 25,969 | 28,929 | 30,862 | 40,493 | 56,139 |
| Net Cash Flow | $-14,524 | $-11,564 | $-9,631 | $-13,269 | $2,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,025 | -42,824 | -19,841 | -55,032 | -40,382 |
| Capital Expenditure | -2,166 | -1,566 | -511 | -642 | -578 |
| Free Cash Flow | -64,191 | -44,390 | -20,352 | -55,674 | -40,960 |